semaglutide, tirzepatide) are required to confirm whether adjunctive GLP-1 agonist therapy and other gut hormone therapies are beneficial post-metabolic surgery in patients with T2DM
If you see an ingredient with a trademark sign () after it on an eye drop ingredient list, and its not identified as a preservative, this may indicate it is a scam pharma eye drop
Use of these agents has been associated with a modest increase in lipase and amylase levels (by 15 and 37%, respectively, in one study 47 ), but this is rarely of any clinical significance
J.RizzaR
J.HarrisM
below Properties of Convex and Concave Functions Some common properties related to Concave and Convex Functions are: First Derivative Test for Convexity/Concavity A function f(x) is convex, If f(x) is non-decreasing i , we have: f(\lambda x_1 + (1-\lambda) x_2) \leq \lambda f(x_1) + (1-\lambda) f(x_2) Consider \( f(x) = x^2 \), then: f(\lambda x_1 + (1-\lambda) x_2) = (\lambda x_1 + (1-\lambda) x_2)^2 Expanding this expression: (\lambda x_1 + (1-\lambda) x_2)^2 = \lambda^2 x_1^2 + 2\lambda(1-\lambda)x_1x_2 + (1-\lambda)^2 x_2^2 On the other hand, we have: \lambda f(x_1) + (1-\lambda) f(x_2) = \lambda x_1^2 + (1-\lambda) x_2^2 Now, comparing both sides: \lambda^2 x_1^2 + 2\lambda(1-\lambda)x_1x_2 + (1-\lambda)^2 x_2^2 \leq \lambda x_1^2 + (1-\lambda) x_2^2 Since \ 2\lambda(1-\lambda) x_1 x_2 \geq 0 ,the inequality holds
